[{"address1": "830 Winter Street", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "781 999 0232", "website": "https://www.q32bio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti\u0096interleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb \u0096 CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.", "fullTimeEmployees": 42, "companyOfficers": [{"maxAge": 1, "name": "Ms. Jodie Pope Morrison", "age": 48, "title": "CEO & Director", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 860740, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Lee H. Kalowski M.B.A.", "age": 43, "title": "CFO & President", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 750793, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shelia M. Violette Ph.D.", "age": 63, "title": "Co-founder, Chief Scientific Officer & President of Research", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 619930, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Saul W. Fink Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Appugliese J.D.", "title": "Senior VP & Head of People", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maria  Marzilli M.P.H.", "title": "Executive Vice President of Corporate Strategy & Program Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Adrien  Sipos", "title": "Interim Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 7, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.79, "open": 1.75, "dayLow": 1.5875, "dayHigh": 1.82, "regularMarketPreviousClose": 1.79, "regularMarketOpen": 1.75, "regularMarketDayLow": 1.5875, "regularMarketDayHigh": 1.82, "payoutRatio": 0.0, "forwardPE": -0.30410448, "volume": 129438, "regularMarketVolume": 129438, "averageVolume": 1334698, "averageVolume10days": 224210, "averageDailyVolume10Day": 224210, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 19882088, "fiftyTwoWeekLow": 1.345, "fiftyTwoWeekHigh": 53.79, "fiftyDayAverage": 1.8918, "twoHundredDayAverage": 8.7386, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -16903888, "profitMargins": 0.0, "floatShares": 9771387, "sharesOutstanding": 12197600, "sharesShort": 556802, "sharesShortPriorMonth": 384785, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.0456, "heldPercentInsiders": 0.06566, "heldPercentInstitutions": 0.73027, "shortRatio": 0.16, "shortPercentOfFloat": 0.16219999, "impliedSharesOutstanding": 12197600, "bookValue": -1.003, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -52304000, "trailingEps": -4.34, "forwardEps": -5.36, "lastSplitFactor": "1:18", "lastSplitDate": 1711411200, "enterpriseToEbitda": 0.311, "52WeekChange": -0.9501393, "SandP52WeekChange": 0.19554341, "quoteType": "EQUITY", "currentPrice": 1.63, "targetHighPrice": 20.0, "targetLowPrice": 6.0, "targetMeanPrice": 12.0, "targetMedianPrice": 10.0, "recommendationMean": 2.33333, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 54832000, "totalCashPerShare": 4.495, "ebitda": -54287000, "totalDebt": 18046000, "quickRatio": 4.754, "currentRatio": 5.057, "returnOnAssets": -0.35952, "returnOnEquity": -4.91671, "grossProfits": -34575000, "freeCashflow": -38044000, "operatingCashflow": -54083000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "QTTB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1754690032, "regularMarketTime": 1754683200, "exchange": "NCM", "messageBoardId": "finmb_669405676", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "shortName": "Q32 Bio Inc.", "postMarketChange": 0.0700001, "regularMarketChange": -0.16, "regularMarketDayRange": "1.5875 - 1.82", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1334698, "fiftyTwoWeekLowChange": 0.28499997, "fiftyTwoWeekLowChangePercent": 0.21189588, "fiftyTwoWeekRange": "1.345 - 53.79", "fiftyTwoWeekHighChange": -52.16, "fiftyTwoWeekHighChangePercent": -0.96969694, "fiftyTwoWeekChangePercent": -95.01393, "earningsTimestamp": 1754539200, "earningsTimestampStart": 1762432200, "earningsTimestampEnd": 1762432200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.34, "epsForward": -5.36, "fiftyDayAverageChange": -0.26180005, "fiftyDayAverageChangePercent": -0.13838674, "twoHundredDayAverageChange": -7.1085997, "twoHundredDayAverageChangePercent": -0.81347126, "priceToBook": -1.6251246, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "firstTradeDateMilliseconds": 1522243800000, "postMarketChangePercent": 4.29448, "postMarketPrice": 1.7, "longName": "Q32 Bio Inc.", "hasPrePostMarketData": true, "regularMarketChangePercent": -8.93855, "regularMarketPrice": 1.63, "displayName": "Q32 Bio", "trailingPegRatio": null, "__fetch_time": "2025-08-09"}]